Skip to main content
Koichi Yuki, MD, Anesthesiology, Boston, MA

Koichi Yuki MD

Pediatric Anesthesiology


Professor, Anaesthesia-Children's Hospital, Harvard Medical School

Join to View Full Profile
  • 300 Longwood AveBoston, MA 02115

  • Phone+1 617-355-6000

Dr. Yuki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Boston Children’s Hospital/Harvard Medical School
    Boston Children’s Hospital/Harvard Medical SchoolFellowship, Pediatric Anesthesiology, 2005 - 2007
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Anesthesiology, 2002 - 2005
  • University of Hawaii
    University of HawaiiInternship, Transitional Year, 2001 - 2002
  • Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
    Graduate School of Medicine and Faculty of Medicine, The University of TokyoClass of 1999

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2004 - 2025
  • HI State Medical License
    HI State Medical License 2001 - 2002
  • Anesthesiology
    American Board of Anesthesiology Anesthesiology
  • Pediatric Anesthesiology
    American Board of Anesthesiology Pediatric Anesthesiology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Differential Effect of Propofol and Isoflurane on Macrophage‐1 Antigen 
    Boston Children's Hospital, Boston, MA, USA - 10/14/2014

Press Mentions

  • Anesthetic Drug Sevoflurane Improves Sepsis Outcomes, Animal Study Reveals
    Anesthetic Drug Sevoflurane Improves Sepsis Outcomes, Animal Study RevealsSeptember 12th, 2019

Grant Support

  • CD11c as a novel target to improve neutrophil effector functions and sepsis outcomeBOSTON CHILDREN'S HOSPITAL2023–2026
  • CD11c as a novel target to improve neutrophil effector functions and sepsis outcomeBOSTON CHILDREN'S HOSPITAL2023–2026
  • CD11c as a novel target to improve neutrophil effector functions and sepsis outcomeBOSTON CHILDREN'S HOSPITAL2023–2026
  • The role of damage-associated molecular patterns in perioperative morbidities and mortalities of pediatric congenital heart diseasesBOSTON CHILDREN'S HOSPITAL2022–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: